XML 24 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Goodwill and Other Intangible Assets
 3 Months Ended
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Disclosure
4. Goodwill and Other Intangible Assets
Goodwill
The following table summarizes the changes in the carrying amount of goodwill by segment and in total:
(in millions)PharmaceuticalMedical (1)Total
Balance at June 30, 2022$2,673 $3,182 $5,855 
Foreign currency translation adjustments and other— (26)(26)
Goodwill impairment— (154)(154)
Balance at September 30, 2022$2,673 $3,002 $5,675 
(1)At September 30, 2022, the Medical segment accumulated goodwill impairment loss was $3.6 billion.
During the three months ended September 30, 2022, the Medical Unit continued to experience adverse financial results related to inflationary impacts and PPE demand and pricing. Due to the risks and uncertainties related to these impacts and an increase in the risk-free interest rate used in the discount rate, we elected to bypass the qualitative assessment and perform quantitative goodwill impairment testing for the Medical Unit.
Our determination of the estimated fair value of the Medical Unit is based on a combination of the income-based approach (using a discount rate of 10.5 percent and a terminal growth rate of 2 percent), and market-based approaches. Additionally, we assigned a weighting of 80 percent to the discounted cash flow method, 10 percent to the guideline public company method, and 10 percent to the guideline transaction method. The carrying amount exceeded the fair value, which resulted in a pre-tax impairment charge of $154 million for the Medical Unit, which was recognized during the three months ended September 30, 2022 and is included in impairments and (gain)/loss on disposal of assets, net in our condensed consolidated statements of earnings. This impairment charge was driven by an increase in the discount rate primarily due
to an increase in the risk-free interest rate. The carrying value of the Medical Unit at September 30, 2022 after recognizing the impairment charge was $6.7 billion, of which $1.8 billion was goodwill.
Other Intangible Assets
The following tables summarize other intangible assets by class at:
September 30, 2022
(in millions)Gross
Intangible		Accumulated
Amortization		Net
Intangible		Weighted- Average Remaining Amortization Period (Years)
Indefinite-life intangibles:
Trademarks and patents$11 $— $11 N/A
Total indefinite-life intangibles11 — 11 N/A
Definite-life intangibles:
Customer relationships3,206 2,157 1,049 10
Trademarks, trade names and patents546 361 185 8
Developed technology and other1,037 590 447 9
Total definite-life intangibles4,789 3,108 1,681 9
Total other intangible assets$4,800 $3,108 $1,692 N/A
June 30, 2022
(in millions)Gross
Intangible		Accumulated
Amortization		Net
Intangible
Indefinite-life intangibles:
Trademarks and patents$11 $— $11 
Total indefinite-life intangibles11 — 11 
Definite-life intangibles:
Customer relationships3,272 2,165 1,107 
Trademarks, trade names and patents552 360 192 
Developed technology and other1,038 574 464 
Total definite-life intangibles4,862 3,099 1,763 
Total other intangible assets$4,873 $3,099 $1,774 
Total amortization of intangible assets was $71 million and $78 million for the three months ended September 30, 2022 and 2021, respectively. Estimated annual amortization of intangible assets for the remainder of fiscal 2023 through 2027 is as follows: $212 million, $258 million, $233 million, $206 million, and $174 million.